Statistical analysis plan for pooled individual patient data from two landmark randomized trials (INTERACT2 and ATACH-II) of intensive blood pressure lowering treatment in acute intracerebral hemorrhage

Abstract

Background

There is persistent uncertainty over the benefits of early intensive systolic blood pressure lowering in acute intracerebral hemorrhage. In particular, over the timing, target, and intensity of systolic blood pressure control for optimum balance of potential benefits (i.e. functional recovery) and risks (e.g. cerebral ischemia).

Aims

To determine associations of early systolic blood pressure lowering parameters and outcomes in patients with a hypertensive response in acute intracerebral hemorrhage. Secondary aims are to identify the modifying effects of patient characteristics and an optimal systolic blood pressure lowering profile.

Methods

Individual participant data pooled analyses of two large, multicenter, randomized controlled trials specifically undertaken to assess the effects of early intensive systolic blood pressure reduction on clinical outcomes in acute intracerebral hemorrhage: the Intensive Blood Pressure in Acute Intracerebral Hemorrhage Trial (INTERACT2) and the Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH-II) trial. Combined data will include baseline characteristics; systolic blood pressure in the first 24 h; process of care measures; and key efficacy and safety outcomes.

Outcomes

The primary outcome is functional recovery, defined by an ordinal distribution of scores on the modified Rankin scale at 90 days post-randomization. Secondary outcomes include various standard binary cut-points for disability-free survival on the modified Rankin scale, and health-related quality of life at 90 days. Safety outcomes include symptomatic hypotension requiring corrective therapy and early neurologic deterioration within 24 h, and deaths, any serious adverse event, and cardiac and renal serious adverse events, within 90 days.

Discussion

A pre-determined protocol was developed to facilitate successful collaboration and reduce analysis bias arising from prior knowledge of the findings.

Clinical trial registration

URL: http://www.clinicaltrials.gov. Unique identifiers for INTERACT2 (NCT00716079) and ATACH-II (NCT01176565).

Keywords

Intracerebral hemorrhage hypertension treatment outcome clinical trial INTERACT2 ATACH-II

Get full access to this article

View all access options for this article.

References

Willmot

Leonardi-Bee

Bath

PMW

. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 2004; 43: 18–24.

Anderson

Heeley

Huang

et al.

Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013; 368: 2355–2365.

Qureshi

Palesch

Barsan

et al.

Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med 2016; 375: 1033–43.

Shi

Zheng

et al.

Blood pressure management for acute intracerebral hemorrhage: a meta-analysis. Sci Rep 2017; 7: 14345.

Lattanzi

Cagnetti

Provinciali

et al.

How should we lower blood pressure after cerebral hemorrhage? A systematic review and meta-analysis. Cerebrovascular Dis 2017; 43: 207–213.

Gong

Lin

Zhang

et al.

Effects of intensive blood pressure reduction on acute intracerebral hemorrhage: a systematic review and meta-analysis. Sci Rep 2017; 7: 10694.

Boulouis

Morotti

Goldstein

et al.

Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and meta-analysis of randomised trials. J Neurol Neurosurg Psychiatry 2017; 88: 339–345.

Delcourt

Huang

Wang

et al.

The second, main phase, of the intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2): progress update. Int J Stroke 2010; 5: 2–3.

Qureshi

Palesch

. Antihypertensive treatment of acute cerebral hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care 2011; 15: 559–576.

10.

Manning

Hirakawa

Arima

et al.

Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial. Lancet Neurol 2014; 13: 364–373.

11.

Wang

Arima

Heeley

et al.

Magnitude of blood pressure reduction and clinical outcomes in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial study. Hypertension 2015; 65: 1026–1032.

12.

Carcel

Wang

Sato

et al.

Degree and timing of intensive blood pressure lowering on hematoma growth in intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial-2 results. Stroke 2016; 47: 1651–1653.

13.

Arima

Heeley

Delcourt

et al.

Optimal achieved blood pressure in acute intracerebral hemorrhage: INTERACT2. Neurology 2015; 84: 464–471.

14.

Westfall

Tobias

Rom

et al.

Multiple comparisons and multiple tests using SAS, Cary, NC, USA: SAS Institute Inc., 2009.

15.

Chung

Kim

Sanossian

et al.

Association between hyperacute stage blood pressure variability and outcome in patients with spontaneous intracerebral hemorrhage. Stroke 2018; 47: 348–354.

16.

Tanaka

Koga

Kobayashi

et al.

Blood pressure variability on antihypertensive therapy in acute intracerebral hemorrhage: the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study. Stroke 2014; 45: 2275–2279.

17.

Gail

Simon

. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 1985; 41: 361.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.32 MB